FDA Investigator CDR Michael J Mero
CDR Michael J Mero has conducted inspections on 284 sites in 3 countries as of 09 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
284
Last Inspection Date:
09 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Malaysia
FDA Investigators that have inspected at least one site in common with CDR Michael J Mero:
Abdellah El Hajjam,
Alan D Centi,
Albert A Salvador,
Andrew J Howard,
Angela L Hatzenbuhler,
Ann Marie Karnick,
Anthony M Criscuolo, Jr,
Austin B Appler,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Calvin W Edwards,
Carl E Lovrich,
Carrie L Doupnik,
Celia L Hutchinstein,
Chamberlain,
Chyla T Hunter,
Crayton Lee,
Crystal A Harlan,
Cynthia White,
Daniel J Mechenbier,
Daniel R Tammariello,
Daniel W Johnson,
Darlene C Plank Turlington,
Dauksism,
David L Pearce,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Dennis R Hock,
Derek S Dealy,
Dr. Mark J Seaton, PhD,
Dung N Tran,
Edward D Mcdonald,
Edwin L Hobbs,
Eric Rothschild,
Eric S Myskowski,
Erik A Bungo,
Gerald W Kopp,
Gregory E Beichner,
Iqra Iftikhar,
Jacob M Dyer,
James M Mason,
James M Odonnell,
James P Mcevoy,
Jason M Sluzynski,
John D Jaworski,
Joseph L Despins, PhD,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Julianne C Mccullough,
Kelly N Kerr,
Kimberly A Dux,
Kirk A Dymbrowski,
Kyle D Covill,
Kyle S Hobson,
LCDR Margaret Edi Gennaro,
LCDR Susan E Polifko,
Lisa B Orr,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Magdi Ali,
Marc A Jackson, Jr,
Marjorie L Davis,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Duckworth,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael D Omeara,
Michele M Falchek,
Myrick,
Nicole J Clausen,
O'meara,
Princess R Campbell,
Raymond L Cheung,
Richard C Cherry,
Robert D Ogan,
Ronald T Colucci,
Sean D Duke,
Seng Ching Hwang,
Shelley L Waring,
Sherri J Liu,
Stephanie Mangigian, MS/OSH, RN,
Tammy M Phillips,
Teigan M Mule,
Thomas E Friel,
Timothy J Schmidt,
Todd J Maushart,
Tonilynn Coiley,
Tressa T Lewis,
Van Cliff,
Whitney S Reynolds,
William C Brenneman
CDR Michael J Mero's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more